trial
as of 2026-07-01Effectiveness of Ziprasidone for Patients With Schizophrenia
NCTId NCT01198353
at a glance
Phase 4 · Completed
Enrollment 67 (actual)
Sponsored by Soonchunhyang University Hospital
Primary completion 2013-06
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
67 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2010-09
Primary completion
2013-06
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Sponsors
Soonchunhyang University HospitalLead Sponsor
Investigators
1
Han Yong Jung, MD, PhDPrincipal Investigator
Sites
6 total
Ansan, South KoreaBucheon-si, South KoreaIncheon, South KoreaIncheon, South KoreaSeoul, South KoreaSeoul, South Korea
Facts & assertions
4 sourced
Enrollment
67
Phase
PHASE4
Primary Completion Date
2013-06
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator
person